pharmaceutical lawsuit

The Federal Trade Commission and Food and Drug Administration recently told seven companies to either stop selling certain products or revise their claims. In a mass letter to Vital Silver, GuruNanda, LLC, Vivify Holistic Clinic, Herbal Amy LLC, Quinessence Aromatherapy Ltd., Xephyr, LLC doing business as N-Ergetics, and The Jim Baker Show, regulators said these…Read the article

After evidence of a possible life-threatening defect came to light, Medtronic, the medical device giant issued an immediate recall for its MiniMed Insulin Pumps. The recall covers over 300,000 devices which were sold in the United States beginning in June 2017. Medtronic touted these pumps as safe to use for people as young as seven…Read the article

Will dietary supplement keep me safe from coronavirus? Physical health often wards off viral infections. But tread cautiously. In the United States, dietary supplements exist in a legal grey area. So, they are not always safe. Dietary health is essential for overall physical health. Supplements do not replace a healthy diet, but in many cases,…Read the article

Orphan drug affects eyesight Having been widely prescribed for decades, the Elmiron bladder medication has recently been found to be toxic to the retina (damage). An article published by the American Academy of Ophthalmology in 2018 described six patients experiencing pigmentary maculopathy after chronic exposure to Elmiron (pentosan polysulfate sodium) for interstitial cystitis. The following…Read the article

After government inspectors found traces of a cancer-causing chemical in Metformin, the Food and Drug Administration ordered a recall of one of the most commonly-prescribed diabetes drugs in America. FDA officials discovered a dangerous chemical, N-Nitrosodimethylamine, in five different Metformin versions. About 34 million Americans have Type 2 Diabetes, and many of them take some…Read the article

In 2012, the FDA approved the first new prescription weight loss drug in thirteen years: lorcaserin, marketed as Belviq. Available to patients in the US since June 2013 in a twice-daily dose, it was soon (2016) followed by once-a-day Belviq XR. Expectations crushed Nevertheless, this herald of hope for almost one third of Americans rated…Read the article

Heartburn Heaven As recently as August 2019, the ranitidine market was tipped to top a gut-gripping US$ 485.4 million by 2026. Introduced in 1981, this popular antacid – better known as Zantac – was the world’s top-selling prescription drug just six years later. In fact, sweetening the world’s sour stomachs proved a bottomless well of…Read the article

Pharmaceutical giant Johnson & Johnson raised the proverbial white flag, at least to an extent, when it said it would no longer sell its controversial baby powder in the United States and Canada. “Demand for talc-based Johnson’s Baby Powder in North America has been declining due in large part to changes in consumer habits and…Read the article

Recent evidence links the popular heartburn medication to an increased cancer risk, thus FDA demands Zantac recall. The agency wants all ranitidine off store shelves effective immediately. Currently, the Food and Drug Administration is sending letters to Sanofi and other ranitidine manufactures asking them to stop making and shipping product. Additionally, the FDA advises consumers…Read the article

Over-the-counter Zantac (Ranitidine) is already one of the largest-selling antacids in the United States. Annual revenue exceeds $125 million. That market share was expected to triple by 2026. Then, the Food and Drug Administration found a dangerously-high level of a cancer-causing compound in Zantac. The watchdog then ordered Sanofi to stop selling the drug in…Read the article